As this study focused primarily on the discovery of new regulators of IRF5, further investigation of the molecular mechanisms of each candidate will provide new insight into the IRF5 signaling pathway and provide new opportunities for the development of antiviral therapies and therapeutic targets for autoimmune diseases. Here, IRF5 is linked to autoimmune disease.